Omnicell's Q3 2026 revenue and EBITDA beat guidance, and full-year non-GAAP EBITDA guidance rose to $187-193 million while ...
The average one-year price target for Pyxis Tankers (NASDAQCM:PXS) has been revised to $11.73 per share, representing a 15.00% increase from the prior estimate of $10.20 dated September 11, 2026.
On 5/10/24, Pyxis Tankers Inc's 7.75% Series A Cumulative Convertible Preferred Shares (Symbol: PXSAP) will trade ex-dividend, for its monthly dividend of $0.1615, payable on 5/20/24. As a percentage ...
Antibody drug conjugates, or ADCs, are picking up momentum. Of the 11 drugs in this class that have been approved by the FDA, six have reached the market in the last two years. Meanwhile, new ADC ...
Buying Apexigen will give Pyxis Oncology a platform for antibody generation. (flytosky11/iStock/Getty Images Plus) Apexigen’s rapid decline is nearly complete ...
BURLINGAME, Calif.--(BUSINESS WIRE)--Pyxis One, a California-based tech startup that aims to revolutionize marketing and consumer intelligence by providing an all-in-one, codeless AI platform, closed ...
Pyxis Oncology develops innovative therapeutics for hard-to-treat cancers using antibody-drug conjugates and immunotherapies. The company's pipeline includes PYX-201 and PYX-106, targeting multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results